NCT03785587View on ClinicalTrials.gov

A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 21, 2018

Primary Completion Date

September 6, 2019

Study Completion Date

September 6, 2019

Conditions
Primary Axillary Hyperhidrosis
Interventions
DRUG

Sofpironium Bromide Gel, 15%

Sofpironium Bromide Gel, 15%

Trial Locations (1)

72758

Northwest Arkansas Clinical Trials Center, Rogers

Sponsors
All Listed Sponsors
lead

Botanix Pharmaceuticals

INDUSTRY